🔎 Trials Near Me

Hjem › Kreft (alle typer) › Missouri › Kansas City

Kliniske studier for Kreft (alle typer) i Kansas City, MO

21 studier for Kreft (alle typer) søker deltakere på steder i og rundt Kansas City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

RekruttererFase 3
  • St. Lukes Hosp. of Kansas City /ID# 259940, Kansas City
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT04928846

A Study of ASP3082 in Adults With Advanced Solid Tumors

RekruttererFase 1
  • University of Kansas Medical Center, Westwood · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT05382559

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

RekruttererFase 2/3
  • Premier Imaging, Kansas City
  • St. Joseph Medical Center, Kansas City
  • MidAmerica Cancer Care - American Oncology Partners, Kansas City
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06989437

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

RekruttererFase 3
  • University of Kansas Cancer Center, Westwood · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06901531

Prospective Study to Assess a Diagnostic Aid for Cancer

RekruttererObservasjonsstudie
  • Aton Health, Kansas City
Alder 45 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07046260

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

RekruttererFase 2/3
  • Kansas University Medical Center, Westwood · 5 mi unna
Alle aldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT03435796

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

RekruttererFase 1/2
  • Children's Mercy Hospital ( Site 3024), Kansas City
1 Month – 17 Years · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06941272

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

RekruttererFase 1/2
  • The University of Kansas Cancer Center, Westwood · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06634589

A Phase 1/1b Study of IAM1363 in HER2 Cancers

RekruttererFase 1
  • Saint Luke's Cancer Institute, Kansas City
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06253871

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RekruttererFase 3
  • The University of Kansas Cancer Center - Westwood, Westwood · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06119581

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

RekruttererObservasjonsstudie
  • University of Kansas, Westwood · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06163534

Project: Every Child for Younger Patients With Cancer

RekruttererObservasjonsstudie
  • Children's Mercy Hospitals and Clinics, Kansas City
Opp til 25 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT02402244

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

RekruttererFase 2
  • Children's Mercy Hospital, Kansas City
Alder 1 til 39 · Alle kjønn · Oppdatert 7. aug. 2026 · NCT05999994

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

RekruttererFase 2
  • 334, Kansas City
Alder 18 og eldre · Kvinner · Oppdatert 16. jul. 2026 · NCT06906341

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

RekruttererFase 1/2
  • Saint Luke's Cancer Institute, Kansas City
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT05768139

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

RekruttererFase 1/2
  • The University of Kansas Cancer Center, Westwood · 5 mi unna
Alder 18 til 70 · Alle kjønn · Oppdatert 11. jun. 2026 · NCT05361174

Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer

Rekrutterer
  • Children's Mercy Hospital, Kansas City
Alder 15 til 29 · Alle kjønn · Oppdatert 22. mai 2026 · NCT05958316

Beat Childhood Cancer Specimen Banking and Data Registry

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Children's Mercy Hospitals and Clinics, Kansas City
Alle aldre · Alle kjønn · Oppdatert 3. feb. 2026 · NCT04715178

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservasjonsstudie
  • Massive Bio SYNERGY-AI site, Kansas City
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Rekrutterer
  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Hospital- Westwood Cancer Center, Westwood · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 27. nov. 2024 · NCT03860883

Barrett's Esophagus Related Neoplasia (BERN) Project

RekruttererObservasjonsstudie
  • Kansas city VA Medical center, Kansas City
Alder 18 og eldre · Alle kjønn · Oppdatert 22. nov. 2024 · NCT00590239

Kreft (alle typer)-studier i andre byer

Andre studier i Kansas City

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.